5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L-DOPA
- 1 September 1971
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 3 (4), 232-235
- https://doi.org/10.1007/bf00565012
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- STUDIES OF THE MONOAMINE METABOLISM IN THE CENTRAL NERVOUS SYSTEM IN JAKOB-CREUTZFELDT DISEASEActa Neurologica Scandinavica, 1971
- Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sexNeuropharmacology, 1971
- Evidence for a central noradrenaline receptor stimulation by clonidineLife Sciences, 1970
- The effect of L-Dopa on monoamine metabolites in Parkinson's diseaseCellular and Molecular Life Sciences, 1970
- 5‐Hydroxyindoleacetic Acid in Ventricular Cerebrospinal Fluid and Brain of Normal and Hydrocephalic Dogs after Administration of 5‐Hydroxytryptophan. IIActa Pharmacologica et Toxicologica, 1968
- Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's DiseaseNature, 1968
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967
- Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecidLife Sciences, 1966
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964
- Are Dihydroxyphenylalanine Decarboxylase and 5-Hydroxytryptophan Decarboxylase Individual Enzymes?Acta Physiologica Scandinavica, 1960